Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
- Market Cap ₹ 37,190 Cr.
- Current Price ₹ 1,820
- High / Low ₹ 2,372 / 1,296
- Stock P/E 45.0
- Book Value ₹ 199
- Dividend Yield 0.25 %
- ROCE 20.8 %
- ROE 24.2 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 43.5% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.7%
Cons
- Stock is trading at 9.16 times its book value
- Promoter holding has decreased over last quarter: -0.58%
- The company has delivered a poor sales growth of 11.9% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 Nifty Smallcap 100 Nifty Alpha 50
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,095 | 1,364 | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 4,890 | 5,483 | 6,778 | |
| 989 | 1,236 | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,722 | 4,185 | 5,317 | |
| Operating Profit | 106 | 128 | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,168 | 1,298 | 1,461 |
| OPM % | 10% | 9% | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 24% | 24% | 22% |
| 39 | 6 | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 73 | 80 | 39 | |
| Interest | 31 | 45 | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 163 | 193 |
| Depreciation | 57 | 68 | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 241 | 278 | 377 |
| Profit before tax | 57 | 21 | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 888 | 936 | 930 |
| Tax % | 38% | 71% | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | 16% | |
| 29 | -19 | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 791 | 779 | |
| EPS in Rs | 974.49 | -0.84 | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.66 | 38.11 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% | 12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 14% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 43% |
| 3 Years: | 31% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 31% |
| 3 Years: | 36% |
| 1 Year: | 37% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 25% |
| 3 Years: | 29% |
| Last Year: | 24% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.33 | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves | 580 | 568 | 672 | 759 | 831 | 877 | 932 | 916 | 1,284 | 1,927 | 2,679 | 3,422 | 3,855 |
| 333 | 362 | 258 | 217 | 802 | 813 | 952 | 826 | 723 | 884 | 1,627 | 2,428 | 2,340 | |
| 242 | 241 | 424 | 468 | 692 | 746 | 813 | 833 | 931 | 1,155 | 1,123 | 1,216 | 1,342 | |
| Total Liabilities | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 7,742 |
| 738 | 913 | 1,054 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,266 | 4,399 | |
| CWIP | 20 | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 86 | 135 |
| Investments | 51 | 52 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 | 1,435 |
| 346 | 385 | 402 | 417 | 637 | 729 | 711 | 678 | 964 | 1,323 | 1,624 | 1,835 | 1,773 | |
| Total Assets | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 7,742 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110 | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 | 986 | |
| -168 | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 | -1,325 | |
| 57 | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 488 | 544 | |
| Net Cash Flow | -1 | -6 | 42 | 28 | -22 | 89 | 7 | -2 | 59 | -4 | 97 | 205 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 45 | 38 | 34 | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 | 37 |
| Inventory Days | 64 | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 44 | 40 |
| Days Payable | 198 | 146 | 152 | 173 | 200 | 177 | 177 | 221 | 180 | 224 | 214 | 185 |
| Cash Conversion Cycle | -90 | -51 | -70 | -98 | -100 | -95 | -111 | -150 | -108 | -158 | -138 | -108 |
| Working Capital Days | 2 | -30 | -12 | -11 | -10 | -10 | -22 | -38 | -16 | -25 | -30 | -17 |
| ROCE % | 8% | 7% | 9% | 14% | 9% | 9% | 14% | 2% | 25% | 32% | 26% | 21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
20h - Newspaper Publication of Un-audited (Standalone and Consolidated) financial results for the quarter and period ended December 31, 2025.
-
Filing Of Affidavit Of Service Of Notice To Statutory Authorities
1d - Filed affidavit (Feb 13, 2026) proving service of notices for NCLT-approved amalgamation; hearing listed Feb 27, 2026? , checklist: ["Review announcement content to identify the …
-
Announcement under Regulation 30 (LODR)-Investor Presentation
1d - Investor presentation for the quarter and period ended December 31 2025
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - Q3 FY26 consolidated revenue ₹21,512 Mn; UK Practice Plus acquisition effective Nov 6, 2025; Adj. PAT ₹2,548 Mn.
-
Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Period Ended December 31 2025
1d - Q3FY26 consolidated revenue ₹53,022m, net profit ₹5,819.9m; acquired PPG UK for GBP188.78m; labour-code charge ₹509.36m.
Annual reports
Concalls
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
-
Nov 2025Transcript PPT
-
Oct 2025TranscriptAI SummaryPPT
-
Oct 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT REC
-
Aug 2025TranscriptAI SummaryPPT
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptAI SummaryPPT
-
Aug 2020Transcript PPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jun 2020TranscriptAI SummaryPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptAI SummaryPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptAI SummaryPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016TranscriptAI SummaryPPT
Hospital Portfolio[1]
- India: 18 owned/operated hospitals, 2 heart centers, 20 clinics and dialysis centers. Jammu unit is removed and is considered as a part of discontinued operation effective FY25.
- Cayman Islands: 2 hospital.
** - Total:** 42 healthcare facilities with 5,554 operational beds (including Cayman).